$MYOV

Myovant Sciences Ltd

  • NEW YORK STOCK EXCHANGE, INC.
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$18.19 ▲3.706%

Extented Hours

VOLUME

916,408

DAY RANGE

17.16 - 18.29

52 WEEK

10.11 - 30.9

Join Discuss about MYOV with like-minded investors

profile
@lucullus #droscrew
recently

$MYOV @JPwhoisbrown might get a chance in the mid teens in next few weeks....patience is the key

114 Replies 8 👍 10 🔥

profile
@lucullus #droscrew
recently

yeah....i think its almost a certainity...sumitomo own a huge percentage of it....THE ONLY PROBLEM FOR THEM IS THAT PFE has just signed a big $4 bill deal with MYOV.....they also got a new PDUFA ON jUNE WHICH IS A DEAD CERT....if they get for $45 it will be a very cheap buy

42 Replies 13 👍 15 🔥

profile
@lucullus #droscrew
recently

might get $MYOV at $15 or below @JPwhoisbrown . Buy and wait for 3x at buyout

91 Replies 14 👍 13 🔥

profile
@JPwhoisbrown #droscrew
recently

but but MYOV

69 Replies 6 👍 15 🔥

profile
@JPwhoisbrown #droscrew
recently

luc your MYOV back on the 100 ema now

123 Replies 12 👍 8 🔥

profile
@lucullus #droscrew
recently

MYOV just not selling off...was hoping to pick some up $15-16ish

64 Replies 13 👍 14 🔥

profile
@lucullus #droscrew
recently

Also waiting for a dip towards 15 on my old favourite $MYOV. great catalyst coming and i think it gets bought later this year

98 Replies 9 👍 12 🔥

profile
@lucullus #droscrew
recently

instant worldwide revenue coming $myov WAY plus big one off payment etc

81 Replies 12 👍 11 🔥

profile
@lucullus #droscrew
recently

$myov SUMITOMO BEEN BUYING UP BIG CHUNKS OF THIS AT GOOD PRICES, looking to buy it out on upcoming pdufa i am sure. But boom out of nowhere comes PFE with a big deal for $MYOv....i assume PFE buys it out now and sumitomo makes big money on its stock but misses out on the revenue stream. $PFE now WILL BE ABLE TO TAKE ON $ABBV with a superior product

110 Replies 11 👍 11 🔥

profile
@Carlos-carvan58 #ivtrades
recently

328 $MYOV 100 15 JAN 21 35 CALL @1.30 LMT

134 Replies 15 👍 8 🔥

profile
@lucullus #droscrew
recently

$MYOV I knew the option action for Jan looked suspect, thankfully I bought half my position back after the pdufa

125 Replies 15 👍 10 🔥

profile
@dros #droscrew
recently

$MYOV (+20.9% pre) Myovant shares soar premarket on news of Pfizer $PFE cancer drug deal worth up to $4.2 billion - MW

67 Replies 15 👍 13 🔥

profile
@lucullus #droscrew
recently

@JPwhoisbrown a lot of action in $MYOV options for jan $35s but a few other as well

90 Replies 9 👍 11 🔥

profile
@JPwhoisbrown #droscrew
recently

you're better at it then I..still a good win play > @lucullus said: sold my $MYOV friday JP when it couldnt get going, definetly going to pick it up again. I reckon its a 3 or 4 bagger if it fads a bit at some point next year

72 Replies 8 👍 7 🔥

profile
@lucullus #droscrew
recently

sold my $MYOV friday JP when it couldnt get going, definetly going to pick it up again. I reckon its a 3 or 4 bagger if it fads a bit at some point next year

107 Replies 6 👍 6 🔥

profile
@lucullus #droscrew
recently

tHE ACTION IN THESE SMALL BIOS IS SO CORRUPT.... $MYOV just got its drug approved and they snuffed out the bounce in 5 mins....biggest vlume in 5 mins in months

93 Replies 6 👍 12 🔥

profile
@lucullus #droscrew
recently

MYOV news ?

129 Replies 6 👍 9 🔥

profile
@Navneet #droscrew
recently

i have been seeing $myov 35 calls flow since few days

73 Replies 8 👍 10 🔥

profile
@JPwhoisbrown #droscrew
recently

luc that myov retracted off its previous highs perfectly

150 Replies 14 👍 14 🔥

profile
@lucullus #droscrew
recently

@JPwhoisbrown $MYOV ATH

116 Replies 15 👍 10 🔥

profile
@lucullus #droscrew
recently

have you been following $MYOV JP

52 Replies 12 👍 12 🔥

profile
@lucullus #droscrew
recently

$MYOV having a goodday 5 weeks to approval

91 Replies 10 👍 13 🔥

profile
@lucullus #droscrew
recently

They are going to buy $MYOV i reckon

138 Replies 8 👍 12 🔥

profile
@lucullus #droscrew
recently

Sumitomo has been buying a big stake in $MYOV . They face cashflow issues in not to distant future they are looking for a replecement

72 Replies 12 👍 7 🔥

profile
@lucullus #droscrew
recently

$MYOV is setting up for another run i think....could go lower yet but news on the 20th Dec.....drug will get green light and i think the company will be taken out by the big block buyer between 8-15 a few months ago....probably in the 40-50 dollar area

109 Replies 11 👍 6 🔥

profile
@lucullus #droscrew
recently

nice cup and handle forming on MYOV

122 Replies 10 👍 13 🔥

profile
@dros #droscrew
recently

$MYOV chart looks real nice here lucu

46 Replies 7 👍 6 🔥

profile
@lucullus #droscrew
recently

@JPwhoisbrown quite a lot of open interest this friday expiration on MYOV. LETS SEE IF THEY GET PAID

83 Replies 13 👍 6 🔥

profile
@JPwhoisbrown #droscrew
recently

that MYOV touched 20 today..25 more to go @lucullus

128 Replies 9 👍 11 🔥

profile
@lucullus #droscrew
recently

ISI $MYOV BUY PT 55. — 59 page deep dive Relugolix in Prostate Cancer Deep Dive: Vastly Underappreciated Opportunity Our deep dive into relugolix for prostate cancer increases our confidence that MYOV is one of the most undervalued companies in biopharma.

58 Replies 10 👍 6 🔥

profile
@lucullus #droscrew
recently

$MYOv they forgot the fuel

149 Replies 13 👍 15 🔥

profile
@lucullus #droscrew
recently

$MYOV freight train leaving the station

44 Replies 13 👍 13 🔥

profile
@lucullus #droscrew
recently

i am buying some $MYOV again today for a swing....this thing could be a 10 x bagger

139 Replies 12 👍 13 🔥

Key Metrics

Market Cap

1.55 B

Beta

1.14

Avg. Volume

0.96 M

Shares Outstanding

90.80 M

Yield

0%

Public Float

0

Next Earnings Date

2021-05-18

Next Dividend Date

Company Information

Website:

HQ: ,

Related News

  • Investing.com

    Robert W. Baird Stick to Their Buy Rating for Myovant Sciences By Investing.com

    25 Mar 2021, 14:07
  • OpenPR

    U.S. Uterine Fibroid Treatment Market | Blue Endo, Boston Scientific Corporation, CooperSurgical, Inc., KARL STORZ SE & Co. KG, Myovant Sciences (Sumitovant Biopharma Ltd.), Halt Medical, Inc., LiNA Medical USA, Merit Medical Systems

    23 Mar 2021, 05:59
  • Benzinga

    The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout

    18 Feb 2021, 13:14
  • Benzinga

    Earnings Scheduled For February 11, 2021

    11 Feb 2021, 08:51
  • Transcript Daily

    Myovant Sciences (MYOV) to Release Quarterly Earnings on Thursday

    09 Feb 2021, 08:42